Hologic Appoints Wayde McMillan to Board, Strengthening Leadership in Women's Health Innovation
- Hologic appoints Wayde McMillan to its Board of Directors, effective April 4, 2025, enhancing governance and expertise.
- McMillan brings extensive financial experience from roles at Solventum, Insulet, and Medtronic, crucial for Hologic's growth.
- Hologic aims to strengthen women's health innovations with McMillan's insights, despite potential challenges in securing qualified leadership.
Hologic Strengthens Leadership with Appointment of Wayde McMillan to Board of Directors
Hologic, Inc., a prominent player in the medical technology sector dedicated to advancing women's health, announces the election of Wayde McMillan to its Board of Directors, effective April 4, 2025. McMillan will also take on a role in the Audit and Finance Committee, enhancing the company's governance framework. His appointment comes at a time when Hologic is keen on fortifying its leadership with professionals who possess extensive industry experience and financial acumen. McMillan’s background, particularly his recent position as Chief Financial Officer (CFO) at Solventum Corporation and previous role at 3M’s Health Care Business Group, positions him as a significant asset in navigating the complexities of the healthcare landscape.
McMillan’s experience in high-level financial roles within the healthcare sector is noteworthy. Before his tenure at Solventum, he excelled as CFO at Insulet Corporation and held leadership positions at Medtronic plc, where he managed the Minimally Invasive Therapies Group. These roles have equipped him with a deep understanding of the financial and operational challenges facing medical technology companies today. Steve MacMillan, Hologic's Chairman, President, and CEO, expresses enthusiasm about the strategic advantages McMillan brings to the Board. His expertise is expected to play a pivotal role in guiding Hologic’s efforts to innovate and deliver effective solutions for women's health, an area that remains a critical focus for the company.
As Hologic continues its commitment to enhancing women’s health through early detection and treatment solutions, McMillan’s election symbolizes a strategic move to bolster the company’s leadership team. The addition of experienced professionals like McMillan is essential for Hologic as it navigates the evolving dynamics of the medical technology industry. The company acknowledges the forward-looking nature of this announcement, highlighting that it encompasses potential risks and uncertainties, including challenges in securing qualified board members or executives. Despite these challenges, Hologic remains dedicated to its mission, aiming to leverage McMillan’s insights to further its objectives in women’s health.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

